If you're wondering, "do I qualify for a GLP-1?", the answer usually comes down to more than your weight alone. Your BMI, health conditions, current medications, medical history, treatment goals, and the specific GLP-1 being considered can all matter.

GLP-1 medicines are prescription drugs, so a clinician needs to decide whether one is appropriate for you. For weight management, FDA-approved options generally have specific BMI and health criteria. Other GLP-1 medicines are approved for conditions like type 2 diabetes or certain cardiovascular risks, so qualifying for one medication doesn't automatically mean you qualify for every GLP-1.

And if you're considering an online prescription, the same principle applies. A legitimate GLP-1 telehealth provider should evaluate your health, not simply approve a medication because you meet a number on a form.

TL;DR: Who May Qualify for a GLP-1?

  • For weight management, FDA-approved GLP-1 or related medicines are generally prescribed to adults with obesity, or adults with overweight plus at least one weight-related health condition, depending on the medication.
  • A BMI of 30 or higher generally falls into the obesity range. A BMI of 27 or higher may qualify for certain weight-management medications when a weight-related condition is also present.
  • Having type 2 diabetes can make you eligible for certain GLP-1 medicines approved for diabetes, but the specific drug and your treatment history still matter.
  • Your clinician will also consider contraindications, other medications, pregnancy status, previous treatment, and conditions that could make a GLP-1 inappropriate.
  • Telehealth can be an option for evaluation and prescribing when clinically appropriate, but legitimate providers still need to review your medical information and follow prescribing laws.
  • "GLP-1 microdosing" isn't a standard FDA-approved treatment category. Starting at a low dose and gradually increasing it is different from creating an unofficial microdosing regimen.

Wondering if a GLP-1 is right for you? Book a $39 online urgent care visit with August AI. A US-licensed clinician can review your symptoms and medical history and prescribe when clinically appropriate, with same-day pharmacy pickup available across all 50 states.

The visit does not guarantee a prescription. For ongoing weight-management treatment, follow-up, or GLP-1 monitoring, you may need a primary care clinician or specialist.

Who usually qualifies for a GLP-1 for weight loss?

The most common eligibility framework for prescription weight-management medications is based on BMI and related health risks.

For several FDA-approved weight-management medications, adults with a BMI of 30 or higher may qualify based on the medication's labeling. Adults with a BMI of 27 or higher may also qualify when they have at least one weight-related condition.

Those conditions can include problems like high blood pressure, abnormal cholesterol, cardiovascular disease, obstructive sleep apnea, or other health problems associated with excess weight. The exact criteria vary by medication and indication.

For example, the FDA-approved indication for Foundayo (orforglipron) covers adults with obesity and adults with overweight who have at least one weight-related medical problem. Wegovy and Zepbound have their own FDA-approved indications and labeling.

That means BMI is useful for determining whether you may fall within the labeled population, but it isn't a prescription by itself.

What if your BMI is below 27?

If your BMI is below 27, you generally wouldn't meet the standard BMI criteria used for FDA-approved weight-management indications.

That doesn't mean a clinician can't discuss your weight, nutrition, metabolic health, or other treatment options with you. It does mean you should be cautious about telehealth companies suggesting that a GLP-1 is appropriate for anyone who simply wants to lose a few pounds.

A legitimate evaluation should look at the reason you're seeking treatment and whether the medication's approved indication fits your situation.

Do I qualify for a GLP-1 if I have type 2 diabetes?

Possibly. Several medications in the GLP-1 class are approved for the treatment of type 2 diabetes, while some are approved for both diabetes-related and weight-management indications.

Your diagnosis alone doesn't determine which medication you should take. A clinician may consider your blood sugar control, other diabetes medications, kidney function, cardiovascular history, weight, side effects, and treatment goals.

It's also important not to assume that a medication approved for diabetes can automatically be prescribed for weight loss in the same way. The FDA-approved indication and your individual circumstances matter.

If you're already taking diabetes medication, tell the clinician about every prescription, over-the-counter medication, and supplement you use before starting a GLP-1. Combining medications can require adjustments and monitoring.

What can disqualify you from taking a GLP-1?

Meeting the BMI criteria doesn't automatically mean a GLP-1 is safe for you.

Before prescribing, a clinician may ask about:

  • Pregnancy or plans to become pregnant
  • A personal or family history of medullary thyroid carcinoma
  • Multiple endocrine neoplasia syndrome type 2
  • Previous pancreatitis
  • Gallbladder problems
  • Kidney problems or dehydration
  • Severe gastrointestinal problems, including gastroparesis
  • Diabetic retinopathy, when relevant
  • Other medications that affect blood sugar or appetite
  • Previous reactions to GLP-1 or related medications

The exact contraindications and warnings depend on the medication. For example, the FDA medication information for Foundayo warns against its use in people with a personal or family history of medullary thyroid carcinoma or MEN 2 and includes additional precautions involving pregnancy, the pancreas, kidneys, gastrointestinal problems, and other conditions.

This is one reason an online questionnaire that asks only for your height and weight isn't enough to establish whether a GLP-1 is appropriate.

Can you get a GLP-1 prescription through telehealth?

In many cases, yes. Telehealth can be used for medication management and evaluation of a range of health conditions. But online prescribing still has to follow federal and state requirements, and the clinician needs to determine that prescribing is medically appropriate.

When comparing GLP-1 telehealth providers, don't focus only on which company advertises the lowest monthly price. Look at what happens before and after the prescription.

What to compare between GLP-1 telehealth providers

  • Clinical evaluation: Does a licensed clinician actually review your medical history, medications, health conditions, and treatment goals?
  • Medication: Does the provider prescribe an FDA-approved medication when appropriate, or primarily promote compounded products?
  • Follow-up: Is there a clinician available to monitor your response and side effects?
  • Pharmacy: Where is the medication dispensed, and can you use a local pharmacy?
  • Total price: Does the advertised price include the clinical visit, medication, shipping, and follow-up, or are these separate?
  • Insurance: Can the service work with your insurance, or is it entirely cash-pay?
  • Medical records: Can you access your visit information and prescription history if you later move your care to another clinician?

Telehealth can make access more convenient, but convenience shouldn't replace a proper medical evaluation. Prescribing clinicians still have to follow applicable licensing and prescribing requirements.

For a full comparison of oral and injectable GLP-1 options, see our guide on GLP-1 pills vs injections.

What is GLP-1 microdosing?

GLP-1 microdosing is a term you'll see frequently in online weight-loss discussions, but it isn't a standard FDA-approved dosing strategy.

Approved GLP-1 medications are generally started at a lower dose and increased according to the medication's prescribing information. This gradual dose escalation is designed to help patients adjust to treatment and can reduce certain gastrointestinal side effects. It shouldn't be confused with creating an independent "microdose" schedule.

Some clinics or online sellers may promote very small doses as a way to lose weight while supposedly minimizing side effects. There isn't a general FDA-approved category of "GLP-1 microdosing" that makes such a regimen appropriate for everyone.

This matters even more with compounded products. The FDA has reported dosing errors involving compounded injectable semaglutide and has received reports of adverse events associated with compounded semaglutide and tirzepatide. Compounded medications aren't FDA-approved and don't undergo the same premarket review for safety, effectiveness, and quality as FDA-approved drugs.

If a clinician recommends a lower starting dose, ask what medication you're taking, what the prescribed dose is, how long you should stay at that dose, and when the dose should be increased.

Does Medicare cover GLP-1 medications?

Medicare GLP-1 coverage depends on why the medication is being prescribed and which Medicare benefit applies.

Medicare Part D already covers certain GLP-1 medicines for some FDA-approved indications, such as type 2 diabetes and certain other approved uses. In 2026, CMS also launched the Medicare GLP-1 Bridge, a temporary demonstration for eligible Part D beneficiaries seeking certain GLP-1 medications specifically for weight management.

The Medicare GLP-1 Bridge began July 1, 2026, and is scheduled to run through December 31, 2027. It isn't universal Medicare coverage. Eligible beneficiaries must meet specific plan and clinical requirements, and prior authorization is required.

For the weight-management Bridge, CMS says an adult may qualify based on a BMI of at least 35, or a BMI of at least 30 with certain qualifying conditions, or a BMI of at least 27 with certain specified conditions like prediabetes, previous heart attack, previous stroke, or symptomatic peripheral artery disease.

The program currently includes Foundayo, Wegovy in its available formulations, and the KwikPen formulation of Zepbound when used for the covered weight-management purpose.

If you're on Medicare, don't assume that meeting a general GLP-1 eligibility rule means your prescription will be covered. The drug, indication, plan, prior authorization requirements, and applicable Medicare pathway all matter.

For a broader explanation of current pricing and Medicare rules, see our guide to what GLP-1s cost in 2026.

What should you expect during a GLP-1 evaluation?

A proper evaluation should be more than a BMI calculator.

A clinician may review your height, weight, and BMI; weight history and previous attempts at weight management; blood pressure and other health measurements; diabetes or prediabetes history; cardiovascular risk factors; current medications and supplements; kidney and liver health; gastrointestinal history; previous experience with GLP-1 medications; family and personal medical history; and treatment goals.

Depending on your situation, the clinician may also recommend laboratory testing or an in-person evaluation before starting treatment.

This is particularly important if you have other medical conditions or take medications that could interact with your treatment plan.

How much does a GLP-1 prescription cost?

Qualifying for a prescription and being able to afford the medication are two different questions.

Your cost can depend on the specific medication, dose, pharmacy, insurance coverage, and whether the medication is being prescribed for an indication your insurance covers.

For people paying cash, manufacturer savings programs and self-pay pricing can sometimes reduce the cost of FDA-approved medications. Prices also change, so check the manufacturer's current pricing before assuming an advertised monthly rate is your long-term cost.

If you have insurance, ask whether the specific GLP-1 is covered for your diagnosis and whether your plan requires prior authorization. A medication may be covered for type 2 diabetes but not for weight management under the same plan.

You can also compare the total cost of the medication with the cost of the clinical evaluation, follow-up visits, and any required monitoring.

Conclusion

If you're searching "do I qualify for a GLP-1," start with the same questions a clinician would ask.

Your BMI can tell you whether you fall within common eligibility ranges for certain weight-management medications, but it doesn't tell the whole story. Your medical history, health conditions, medications, treatment goals, and the specific medication all matter.

Telehealth can be a convenient way to start that conversation, but the provider should still perform a real clinical evaluation. Be especially careful with services that promise guaranteed prescriptions, promote unofficial dosing schedules like GLP-1 microdosing, or make the medication sound appropriate for everyone.

The goal isn't simply to get a GLP-1 prescription. It's to find out whether a particular medication is appropriate for you, and if it is, what treatment and monitoring plan makes sense.

Frequently Asked Questions

GLP-1 costs can vary significantly depending on the specific medication, dose, and pharmacy.

FDA-approved branded GLP-1 medications like Wegovy, Ozempic, Zepbound, and Mounjaro have list prices that can range from around $1,000 to $1,400 per month without insurance. Manufacturer savings programs, coupons, and patient assistance programs may reduce the cost for eligible patients.

Some telehealth programs offer compounded versions of GLP-1 medications at lower monthly prices, but the FDA has raised safety concerns about certain compounded GLP-1 products. A branded, FDA-approved medication is generally the safer choice when available.

Prescription discount programs, GoodRx, and comparing prices at different pharmacies may also affect what you actually pay.

Both are injectable medications used for type 2 diabetes and, in specific formulations, chronic weight management. But they work slightly differently.

Semaglutide (Ozempic, Wegovy, Rybelsus) is a GLP-1 receptor agonist that mimics the action of the GLP-1 hormone. Tirzepatide (Mounjaro, Zepbound) is a dual GIP and GLP-1 receptor agonist, meaning it targets two different hormone pathways.

Clinical trials have shown that both can lead to significant weight loss and blood sugar improvement in appropriate patients, with tirzepatide showing somewhat greater average weight loss in some studies. But individual response varies, and neither is universally better for everyone.

A clinician can help you understand which medication may be a better fit based on your medical history, goals, and other factors.

Often, some weight regain does occur.

Research on GLP-1 medications used for weight management has shown that people typically regain a portion of the weight they lost after stopping the medication. This isn't a sign of personal failure. It happens because the medication was actively helping manage appetite and metabolic factors that influence weight.

For many people, GLP-1 medications are used as long-term treatment rather than short-term interventions, similar to how medications for high blood pressure or high cholesterol are used ongoing. The decision to continue, adjust, or stop should always be made with a clinician who understands your medical history and goals.

For more on what to expect, see our guide on GLP-1 side effects and which ones need a clinician.

Sometimes, yes.

For weight management, GLP-1 medications are typically approved for adults with a BMI of 30 or higher, or a BMI of 27 or higher when combined with at least one weight-related health condition like type 2 diabetes, high blood pressure, or high cholesterol.

If your BMI is under 27, GLP-1 medications may still be prescribed for other approved uses like type 2 diabetes management. But prescribing them for weight loss specifically outside of the approved BMI criteria isn't typically covered by insurance and may not be considered appropriate care by most clinicians.

Some clinics prescribe GLP-1 medications more liberally than the FDA-approved indications. This is called off-label prescribing. Off-label use isn't automatically inappropriate, but it's worth understanding the risks and benefits with a clinician you trust.

Most people notice appetite changes within the first few weeks of starting a GLP-1 medication.

Meaningful weight loss typically begins after several weeks of consistent use and dose adjustments. Clinical trials of GLP-1 medications for weight management have generally shown continued weight loss over 6 to 18 months, with results depending on the specific medication, dose, adherence, and individual factors.

For type 2 diabetes, blood sugar improvements can be seen relatively quickly, often within the first several weeks.

Individual results vary. Some people respond significantly, others more modestly, and a small percentage may not respond well to a particular GLP-1 medication and may benefit from switching to a different option.

Regular follow-up with your clinician helps monitor progress and adjust the treatment plan if needed.